Doctor Soojin Kim
Busan (Korea (Republic of))
Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention
Event: ESC Congress 2018
Topic: Antiplatelet Drugs
Session: Pharmacogenetics - New sights on the horizon
Comparison of influencing factors on platelet reactivity in various platelet function test after percutaneous coronary interventions
Event: ESC Congress 2017
Topic: Ischaemia, experimental studies
Session: Coronary artery disease: from bench to bedside
ESC 365 is supported by
